Abstract: Rheumatoid arthritis is an autoimmune disease characterized by chronic joint inflammation and progressive destruction of cartilage and bone which leads to ultimately loss of function and pain. Activated synovial fibroblasts are key effector cells in the pathogenesis of rheumatoid arthritis. In the recent years, epigenetic changes including DNA methylation, histone acetylation and other histone modifications were identified that are associated with an intrinsic activation and the aggressive phenotype of these cells. So far, no therapies targeting rheumatoid arthritis synovial fibroblasts exist. This review comprises recent research efforts that propose epigenetic mechanisms behind the activation of rheumatoid arthritis synovial fibroblasts and other cell types. This review comprises recent research efforts that reveal the mechanisms behind the intrinsic activation of RASF by investigating epigenetic changes ( Figure 1 ) and summarizes data available from other cell types.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by a systemic inflammation, joint destruction, disability and pain. Despite enormous research efforts the underlying cause of the disease is unknown and still no cure exists. Joint resident rheumatoid arthritis synovial fibroblasts (RASF) emerged as key players in the pathogenesis of RA. In addition to macrophages and lymphocytes, also RASF are capable of producing a large set of inflammatory cytokines and chemokines and thereby actively contribute to the inflammatory state in RA. Their intrinsic activation, the inhibition of apoptosis and the recruitment of inflammatory cells including macrophages and lymphocytes, are the major reasons for the excessive hyperplasia of the synovial tissue in RA joints [1] . The importance of these cells in disease progression was further emphasized by functional studies of RASF in the severe immune deficient (SCID) mouse model; RASF, co-implanted with cartilage under the renal capsule of SCID mice were shown to be capable not only to invade into cartilage in the absence of a functioning immune system but also to migrate [2] .
This review comprises recent research efforts that reveal the mechanisms behind the intrinsic activation of RASF by investigating epigenetic changes ( Figure 1 ) and summarizes data available from other cell types.
What is epigenetics?
Originally, epigenetic mechanisms were considered as heritable changes in gene function that were not explainable by changes in the DNA sequence. A more revised definition of epigenetics is the structural adaption of chromosomal regions in order to register, signal or perpetuate altered activity states [3] . Epigenetic modifications including DNA methylation and covalent histone modifications such as acetylation, methylation and ubiquitination alter the accessibility of DNA to the transcription machinery. An increasing amount of proteins that attach ("writers") or remove ("erasers") modifications to DNA and histones or that bind ("readers") to a specific epigenetically modified site have emerged as key players in the regulation of gene expression [4] . Most chromatin marks are highly dynamic and have the capability of influencing transcription by multiple mechanisms; first, they designate chromatin structure and therefore, determine the accessibility of DNA for regulatory proteins; second, they recruit remodeling enzymes that utilize the hydrolysis of ATP to reposition nucleosomes; and third, they mediate the cooperation between pioneer and secondary transcription factors Histone acetylation on lysines is regulated by the opposing activity of two enzyme families, histone acetyl transferases (HATs) and histone deacetylases (HDACs). Histone acetylation neutralizes lysine`s positive charges, an action that has the potential to weaken the interactions between DNA and histones. HDACs are thought to stabilize the local chromatin structure by restoring the positive charges in lysine residues. Therefore, they are mainly considered as transcriptional repressors [5] .
Unlike acetylation, histone methylation does not alter the charge of histone proteins. Histone methylation mainly occurs at lysine and arginine residues of histones H3 and H4 which can be mono-, di-(lysines, arginines) and trimethylated (lysines) [5] . Depending on the position and the degree of methylation, histone methylation marks can be associated with transcriptional activation or silencing. The polycomb repressive complex 2 with its enzymatic subunit histone methyltransferase enhancer of zeste homologue 2 (EZH2) is responsible for the trimethylation of the repressive mark H3K27me3 (Histone 3 lysine 27 trimethylation) [7] .
Today two families of proteins, the lysine-specific demethylase family and the Jumonji C family are known to have histone demethylase activity [8] .
In contrast to the above described histone modifications, histone ubiquitination and sumoylation result in larger covalent modifications of histones. Whereas ubiquitination can be associated with transcriptional silencing, as well as with transcriptional initiation and elongation, histone sumoylation is associated with repressive functions. Sumoylation targets mainly histone lysines that are modified by the action of E1, E2, and E3 enzymes which covalently attach small ubiquitin-like modifier molecules (SUMO) [5] .
In the following sections we discuss recent findings on the impact of DNA methylation and histone modifications studied so far in the context of RA (Figure 2 , Table 1 ).
DNA methylation
RASF display a DNA methylome signature that distinguishes them from osteoarthritis synovial fibroblasts (OASF) and normal SF [9,10]. Whereas Karouzakis et al. 
Histone acetylation
In the last eight years certain beneficial effects of HDAC inhibitors in therapeutic as well as preventive approaches in different animal models of RA have been reported [24] [25] [26] [27] [28] .
Although some decrease in disease severity was shown, these studies have in common that the used inhibitors lack specificity for a single HDAC isoform and the underlying mechanisms reduced IL6 mRNA stability in macrophages and RASF. However, the identified mechanism was not applicable for the regulation of IL8 and MMP1 [37] . Furthermore, the HDAC inhibitors MS-275 and SAHA suppressed the LPS-induced nuclear accumulation of NF-КB p65 in human rheumatoid arthritis synovial fibroblastic E11 cells and THP1 monocytes [38] .
These results point to the fact that not all observed beneficial effects of HDAC inhibitors in vitro and in vivo are due to epigenetic modifications and that there is a variety and likely gene-specific mode of action of different HDAC inhibitors on defined target genes.
Furthermore, nutritional influences might significantly alter the state of acetylation. For example, three to six hours after broccoli sprout consumption HDAC activity is reduced and H3 and H4 acetylation are modulated [39] .
Other histone modifications
So far, only one report exists investigating the functional interaction of sumoylation and epigenetic changes in RASF. RASF have intrinsically high levels of the small ubiquitin like modifier (SUMO)-1 paralleled by decreased levels of its specific protease SENP1. Transient overexpression of SENP1 in RASF reduced H4 acetylation in the MMP1 promoter and consequently MMP1 expression, leading to a decreased invasiveness. The authors further showed that the mechanism was dependent on the presence of HDAC4 [40] .
With respect to the epigenetic modifications regulated by microRNAs we refer to our latest review on this subject [41] .
Conclusions
In recent years, altered DNA methylation patterns and histone modifications including 
